ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves olaparib for gBRCAm Metastatic Pancreatic Adenocarcinoma
January 03, 2020The U.S. Food and Drug Administration (FDA) has approved olaparib (LYNPARZA®, AstraZeneca Pharmaceuticals) for the maintenance treatment of adult patients with deleterious or ... -
Pfizer’s Talzenna cleared for breast cancer
October 19, 2018US regulators have approved Pfizer’s PARP inhibitor Talzenna to treat patients with breast cancer carrying a certain mutation, identified by a companion diagnostic developed by Myriad.
Pharma Sources Insight January 2025
